A9285
α1-Antichymotrypsin from human plasma
≥92.5% (SDS-PAGE), lyophilized powder
Autenticati per visualizzare i prezzi organizzativi e contrattuali.
Scegli un formato
Cambia visualizzazione
| Voi/SKU | Disponibilità | Prezzo |
|---|---|---|
0.1 mg | Per conoscere la disponibilità, visualizza il carrello | CHF 193.00 |
Informazioni su questo articolo
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutartibiological source
human plasma
Quality Segment
assay
≥92.5% (SDS-PAGE)
form
lyophilized powder
mol wt
55-66 kDa
technique(s)
microbiological culture: suitable
UniProt accession no.
storage temp.
−20°C
Gene Information
human ... SERPINA3(12)
General description
α1-Antichymotrypsin (α1-ACT) is also known as serpin peptidase inhibitor, clade A member 3 (SERPINA3). It is a 68 kDa serine protease inhibitor, secreted by the liver. It belongs to the serpin superfamily of protease inhibitors. SERPINA3 is located on human chromosome 14q32.1.
Application
Biochem/physiol Actions
Specific inhibitor of chymotrypsin-like serine proteases.
Specific inhibitor of chymotrypsin-like serine proteases. Promotes amyloid-β polymerization in vitro and in vivo. Levels in plasma and cerebrospinal fluid have been found to correlate with progression of dementia in Alzheimer′s patients and induce phosphorylation of tau protein in neurons.
α1-Antichymotrypsin (α1-ACT) can block the functions of various serine proteases like chymotrypsin and cathepsin G. It serves as a potential therapeutic target of endometrial carcinoma (EC).
Packaging
Package size based on protein content.
Physical form
Lyophilized powder containing Tris buffer salt and NaCl.
Disclaimer
RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.
1 of 1
Questo articolo | |||
|---|---|---|---|
| description ≥92.5% (SDS-PAGE), lyophilized powder | description - | description Acute-phase protein present at ~45 mg/100 ml in plasma. | description lyophilized powder |
| biological source human plasma | biological source rabbit | biological source - | biological source human pancreas |
| assay ≥92.5% (SDS-PAGE) | assay - | assay ≥95% (SDS-PAGE) | assay - |
| Gene Information human ... SERPINA3(12) | Gene Information human ... SERPINA3(12) | Gene Information - | Gene Information human ... CTRB1(1504) |
| Quality Level 200 | Quality Level 100 | Quality Level 100 | Quality Level 200 |
| form lyophilized powder | form liquid | form solid | form lyophilized powder |
| storage temp. −20°C | storage temp. −20°C | storage temp. −20°C | storage temp. −20°C |
Classe di stoccaggio
11 - Combustible Solids
Che succede?
WGK 3
Punto di infiammabilità (°F)
Not applicable
Punto di infiammabilità (°C)
Not applicable
Scegli una delle versioni più recenti:
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.